Skip to content

Home Map The News Technology Politics Business Sports Entertainment Science Health World

Global AI-Powered News Intelligence. Real-time headlines, mapped by continent and country, from news sources worldwide.

Powered by AI

Navigate

Home
Map The News
About
Sources & methodology
Sources & methodology
Search

Sections

Technology
Politics
Business
Sports
Entertainment
Science

More

Privacy
Contact
Sitemap
Robots

© 2026 newsGlobal. All rights reserved.

Headlines refresh every 10 minutes.

Home Map Search Topics About

Health

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

The Guardian

HealthThe Guardian·Jun 18, 2026·1 min read

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

Moderna seeks FDA approval of its new shot, mFlusvia, as option for 50 and older US health advisers are debating a new kind of flu vaccine Thursday, the first made with the same mRNA technology that was key to ending the Covid-19 pandemic…

View original source — The Guardian ↗

ShareShare on X Share on Facebook

Related stories

FDA panel recommends mRNA flu vaccine for older adults

HealthJun 18, 2026 · 1 min

FDA panel recommends mRNA flu vaccine for older adults

Key FDA committee unanimously recommends its first vaccine since 2023

HealthJun 19, 2026 · 1 min

Key FDA committee unanimously recommends its first vaccine since 2023

First-ever AI-designed vaccine reaches human trials

ScienceJun 6, 2026 · 1 min

First-ever AI-designed vaccine reaches human trials

HealthJun 5, 2026 · 1 min

New AI-designed ‘universal vaccine’ could future-proof humans against unknown viruses